Marco L. Lolli - Concepedia

Author

Marco L. Lolli

Also Known As

Deepak Kumar, Lolli, M. L., Lolli, Marco L., Lolli, Marco Lucio, M Lolli, M. LOLLI, M. Lolli, Marco L. Lolli, Marco L Lolli, Marco L. Lolli

131

Publications

Citations

H-Index

Concepts

All Affiliations

University of Turin Mario Negri Institute for Pharmacological Research Lund University University of Gothenburg University of Copenhagen

About

Marco L. Lolli is an author at University of Turin specializing in pharmacology, natural sciences, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Natural Sciences	15	16	479
2	Medicine	14	14	517
3	Biochemistry	14	14	444
4	Engineering	3	3	50
5	Biomolecular Engineering	1	1	15

Marco L. Lolli

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
A covalent PIN1 inhibitor selectively targets cancer cells by a dual mechanism of action Elena Campaner, Alessandra Rustighi, Alessandro Zannini, Nature Communications	2017	142
Antiinflammatory, Gastrosparing, and Antiplatelet Properties of New NO-Donor Esters of Aspirin Clara Cena, Marco L. Lolli, Loretta Lazzarato, Journal of Medicinal Chemistry	2003	98
A New Class of Ibuprofen Derivatives with Reduced Gastrotoxicity Marco L. Lolli, Clara Cena, Claudio Medana, Journal of Medicinal Chemistry InflammationMedicinal ChemistryPharmaceutical ScienceAnti-inflammatoryFuroxan Moieties	2001	73
Targeting Myeloid Differentiation Using Potent 2-Hydroxypyrazolo[1,5-<i>a</i>]pyridine Scaffold-Based Human Dihydroorotate Dehydrogenase Inhibitors Stefano Sainas, Agnese Chiara Pippione, Elisa Lupino, Journal of Medicinal Chemistry	2018	68
MDP, a database linking drug response data to genomic information, identifies dasatinib and statins as a combinatorial strategy to inhibit YAP/TAZ in cancer cells Cristian Taccioli, Giovanni Sorrentino, Alessandro Zannini, Oncotarget	2015	62
Design, synthesis, biological evaluation and X-ray structural studies of potent human dihydroorotate dehydrogenase inhibitors based on hydroxylated azole scaffolds Stefano Sainas, Agnese Chiara Pippione, Marta Giorgis, European Journal of Medicinal Chemistry X-ray Structural StudiesMedicinal ChemistryAldehyde DehydrogenaseBiochemistryMedicine	2017	60
Potent and selective aldo-keto reductase 1C3 (AKR1C3) inhibitors based on the benzoisoxazole moiety: application of a bioisosteric scaffold hopping approach to flufenamic acid Agnese Chiara Pippione, Irene Maria Carnovale, Davide Bonanni, European Journal of Medicinal Chemistry Bioisosteric ScaffoldMedicinal ChemistryPharmaceutical ScienceBiochemistryMedicine	2018	49
Bioisosteres of Indomethacin as Inhibitors of Aldo-Keto Reductase 1C3 Marco L. Lolli, Irene Maria Carnovale, Agnese Chiara Pippione, ACS Medicinal Chemistry Letters Medicinal ChemistryBiosynthesisBioorganic ChemistryAldo-keto ReductaseBiochemistry	2019	49
Substituted 4-hydroxy-1,2,3-triazoles: synthesis, characterization and first drug design applications through bioisosteric modulation and scaffold hopping approaches Agnese Chiara Pippione, Franco Dosio, Alex Ducime, MedChemComm	2015	47
Hydroxytriazole derivatives as potent and selective aldo-keto reductase 1C3 (AKR1C3) inhibitors discovered by bioisosteric scaffold hopping approach Agnese Chiara Pippione, Alessandro Giraudo, Davide Bonanni, European Journal of Medicinal Chemistry Medicinal ChemistryAldo-keto ReductaseBiochemistryHydroxytriazole DerivativesMedicine	2017	42

Page 1